Production of recombinant NS1 protein and its possible use in encephalitic flavivirus differential diagnosis

COLLADO, MARÍA SOLEDAD; SPINSANTI, LORENA IVANA; LORCH, MATÍAS SEBASTIÁN; ROTA, ROSANA PAOLA; GOÑI, SANDRA ELIZABETH; ARGÜELLES, MARCELO HORACIO; LOZANO, MARIO ENRIQUE; COLLADO, MARÍA SOLEDAD; SPINSANTI, LORENA IVANA; LORCH, MATÍAS SEBASTIÁN; ROTA, ROSANA PAOLA; GOÑI, SANDRA ELIZABETH; ARGÜELLES, MARCELO HORACIO; LOZANO, MARIO ENRIQUE

PROTEIN EXPRESSION AND PURIFICATION

ACADEMIC PRESS INC ELSEVIER SCIENCE

Año: 2019 vol. 153 p. 18 - 25

1046-5928

Saint Louis encephalitis virus (SLEV) and West Nile virus (WNV) are two of the major causes of arboviral encephalitis in the Americas. The co-circulation of related flaviviruses in the Americas and prior vaccination against flaviviruses pose problems to the diagnostic specificity of serological assays due to the development of cross-reactive antibodies. An accurate diagnosis method capable of differentiating these related viruses is needed. NS1 is a glycosylated, nonstructural protein, of about 46 kDa which has a highly conserved structure. Anti-NS1 antibodies can be detected within 4?8 days after the initial exposure and NS1 is the least cross-reactive of the flaviviral antigens. This study was aimed to generate SLEV and WNV NS1 recombinants proteins for the development of a flavivirus diagnostic test. Local Argentinian isolates were used as the source of NS1 gene cloning, expression, and purification. The protein was expressed in Escherichia coli as inclusion bodies and further purified by metal-chelating affinity chromatography (IMAC) under denaturing conditions. Human sera from SLEV and WNV positive cases showed reactivity to the recombinant NS1 proteins by western blot. The unfolded NS1 proteins were also used as immunogens. The polyclonal antibodies elicited in immunized mice recognized the two recombinant proteins with differential reactivity.